The Role of Conduction System Pacing in Heart Failure: Current Evidence and Future Directions

Area of Science:

• Cardiology
• Electrophysiology
• Heart Failure Management

Background:

• Conduction system disease significantly impacts heart failure (HF) patients.
• Traditional biventricular pacing (BVP) has limitations in certain HF populations.
• Cardiac resynchronization therapy (CRT) non-responders often require alternative pacing strategies.

Purpose of the Study:

• To review the evidence supporting conduction system pacing (CSP) as an alternative to BVP for HF.
• To evaluate CSP's efficacy in patients with left bundle branch block (LBBB) and CRT non-responders.
• To assess the impact of CSP on electrical and mechanical synchronization in HF.

Main Methods:

• Systematic review of studies on CSP in heart failure.
• Analysis of clinical efficacy data for His bundle pacing and left bundle branch area pacing.
• Evaluation of outcomes including left ventricular ejection fraction, QRS duration, and mortality.

Main Results:

• CSP improves electrical and mechanical synchronization, enhancing left ventricular ejection fraction.
• CSP reduces QRS duration and HF-related hospitalizations.
• CSP demonstrates potential for reduced all-cause mortality in select HF patients.

Conclusions:

• CSP offers a promising alternative to BVP, especially for patients with persistent conduction delays or myocardial scar.
• Technical challenges in lead placement and device complications require further attention.
• Larger randomized controlled trials are necessary to establish long-term efficacy and safety of CSP in diverse HF populations.